Intellectual Property Notes

UKIPO launches ‘AI and IP Call for Views’

Glaxo’s purple inhalers fail to get trade mark protection

The Unified Patent Court - on the move again?

UK Supreme Court stays the course in Unwired Planet and Conversant – confirming the approach to FRAND adopted by the lower courts

UK Supreme Court hands down judgment in Unwired Planet

Patent and Pharma Update, August 2020

Judicial Review – Strategies for Pharmaceutical Companies

In the latest episode of HSF's webinar series on the pharmaceutical sector, Andrew Lidbetter, Sanam Zulfiqar Khan, Mark Smyth and Lourdes Fraguas discuss …

Data Class Actions: the threat to business

UK's exit from the UPC now final

Commission launches sector inquiry into the Internet of Things for consumer related products and services

Where is the balance now? Preliminary injunctions in pharmaceutical patent proceedings in 2020 and beyond

Recent decisions of the Federal Court of Australia have significantly changed the way in which parties to pharmaceutical patent litigation should analyse …

The CJEU’s decision in Santen confirms a restrictive interpretation of ‘product’ under article 1(b) and 3(d) of the SPC Regulation, and rejects the possibility of an SPC based on a Marketing Authorisation for a new use of a previously authorised product